Literature DB >> 7714464

Gastrointestinal motility disorders in patients with diabetes mellitus.

H Abrahamsson1.   

Abstract

Disturbed gastric and small intestinal motility is an often overlooked clinical problem. Delayed gastric emptying of liquid and/or solid food in patients with type 1 and type 2 diabetes (gastroparesis diabeticorum) occurs in approximately 50% of the patients. Also, the interdigestive gastric and small intestinal motility is often affected. There is only a weak correlation between symptoms and objectively measurable motor disturbances. Patients with severe upper gastrointestinal symptoms usually have disturbed motility, but most patients with impaired motility are asymptomatic. Recent studies have clearly shown that, in addition to autonomic neuropathy, acute metabolic derangements are likely to contribute to disturbed motility. Elevated glucose levels impair gastric and small intestinal motility during fasting and after food intake. Hyperinsulinemia per se has effects similar to hyperglycaemia on the stomach and small bowel, and may be a mediator of the effects of hyperglycaemia in healthy subjects. The impact of insulin on motility in diabetic patients is still unclear. Treatment of the gastric motility disorder should include a stabilization of gastric emptying. Different therapeutic modes may be useful, e.g. application of prokinetic drugs and optimizing the metabolic situation.

Entities:  

Mesh:

Year:  1995        PMID: 7714464     DOI: 10.1111/j.1365-2796.1995.tb01194.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  20 in total

1.  Changes of gastric emptying rate and gastrin levels are early indicators of autonomic neuropathy in type II diabetic patients.

Authors:  L Migdalis; T Thomaides; C Chairopoulos; C Kalogeropoulou; J Charalabides; F Mantzara
Journal:  Clin Auton Res       Date:  2001-08       Impact factor: 4.435

2.  Intestinal nerve cell injury occurs prior to insulin resistance in female mice ingesting a high-fat diet.

Authors:  Yvonne Nyavor; Rachel Estill; Hannah Edwards; Hailey Ogden; Kaila Heideman; Kiefer Starks; Christopher Miller; George May; Lance Flesch; John McMillan; Martin Gericke; Larry Forney; Onesmo Balemba
Journal:  Cell Tissue Res       Date:  2019-02-18       Impact factor: 5.249

3.  Comparison of Two Different Enteral Nutrition Protocol in Critically Ill Patients.

Authors:  Sibel Büyükçoban; Mert Akan; Uğur Koca; Merih Yıldız Eğlen; Meltem Çiçeklioğlu; Ömür Mavioğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-10-01

4.  Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth.

Authors:  Yoshihisa Urita; Susumu Ishihara; Tatsuo Akimoto; Hiroto Kato; Noriko Hara; Yoshiko Honda; Yoko Nagai; Kazushige Nakanishi; Nagato Shimada; Motonobu Sugimoto; Kazumasa Miki
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

5.  Effects of intravenous infusion of glucose and pancreatic glucagon on abomasal function in dairy cows.

Authors:  K Holtenius; S O Jacobsson; P Holtenius
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

6.  Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.

Authors:  C C Watkins; A Sawa; S Jaffrey; S Blackshaw; R K Barrow; S H Snyder; C D Ferris
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 7.  Treatment of malignant gastric outlet obstruction with stents: an evaluation of the reported variables for clinical outcome.

Authors:  Lene Larssen; Asle W Medhus; Truls Hauge
Journal:  BMC Gastroenterol       Date:  2009-06-17       Impact factor: 3.067

8.  United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.

Authors:  Jolien Schol; Lucas Wauters; Ram Dickman; Vasile Drug; Agata Mulak; Jordi Serra; Paul Enck; Jan Tack
Journal:  United European Gastroenterol J       Date:  2021-04       Impact factor: 4.623

9.  Impact of myenteric plexus alterations on diabetes related gastrointestinal dysmotility.

Authors:  Kyung Sik Park
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

10.  Treatment options for autonomic neuropathies.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.